Diazyme Laboratories, Inc.

Home
United States
Poway, CA
Diazyme Laboratories, Inc.

Diazyme is a clinical chemistry reagent manufacturer that develops IVD assays for use on conventional open channel automated chemistry platforms.

09/25/2025

🌟 Join Us at Medica 2025! 🌟
Diazyme Laboratories is excited to announce our participation in the Medica Trade Fair this November! As one of the world's largest medical trade fairs, Medica provides a fantastic platform for showcasing our latest innovations in diagnostic technology and connecting with industry professionals.
📅 Event Details:
• Date: November 17-20, 2025
• Location: Düsseldorf, Germany
• Booth: Hall 3, Stand -2
We look forward to seeing you there and exploring new opportunities for collaboration and innovation. Don’t miss out on this chance to engage with us and discover how we’re shaping the future of diagnostics!

09/23/2025

Understanding Cardiovascular Risk with Diazyme’s Lp(a) Assay

At Diazyme Laboratories, we recognize the importance of equipping healthcare professionals with advanced tools to assess cardiovascular health. One such tool is our Lipoprotein(a) [Lp(a)] Assay, designed to help clinicians identify a critical genetic risk factor for cardiovascular disease.

Why Lp(a) Matters:
Lipoprotein(a) is a particle in the blood that consists of LDL cholesterol bound to a unique protein called apolipoprotein(a). Elevated Lp(a) levels are associated with an increased risk of atherosclerosis, heart attack, and stroke, independent of traditional lipid markers. Since Lp(a) levels are largely determined by genetics and not significantly influenced by lifestyle changes, specialized testing is essential for identifying patients at risk.

💡 A Step Forward in Cardiovascular Care:
Diazyme’s Lp(a) assay is part of our commitment to advancing diagnostic solutions for cardiovascular health. By identifying patients with elevated Lp(a), clinicians can take proactive steps to manage cardiovascular risk through tailored interventions and monitoring.

Learn more about our Lp(a) assay and other diagnostic tools:
https://bit.ly/3MlnU6y

Let’s work together to improve heart health and support better outcomes for patients.

09/18/2025

September is Sepsis Awareness Month
Sepsis affects millions of lives every year, often progressing rapidly and unpredictably. Early detection is critical to improving outcomes. At Diazyme Laboratories, we’re committed to supporting healthcare professionals in the fight against sepsis with our Procalcitonin (PCT) Assay, designed for rapid, reliable diagnosis.

Why PCT? Procalcitonin is a powerful biomarker that helps clinicians detect bacterial infections and monitor the severity of sepsis. Our PCT Assay delivers timely, accurate results, giving providers the insights they need to make informed, life-saving decisions.

Let’s raise awareness and empower our healthcare community with the tools they need to combat sepsis head-on.
Together, we can make a difference. Join us in recognizing and learn more about how Diazyme’s PCT Assay can support early diagnosis and improved patient care.

Learn more here: https://bit.ly/3X5DXdW

09/10/2025

🔬 Understanding the Role of the PLAC™ Test in Managing High Cholesterol 🔬

When it comes to cardiovascular health, cholesterol levels are crucial, but they don't tell the whole story. That's where the PLAC™ Test comes into play. While it’s not a direct measure of cholesterol, this test offers valuable insights into cardiovascular risk that complement traditional lipid panels.

Here’s how the PLAC™ Test is relevant:

Complementary to Lipid Testing: The PLAC™ Test provides additional information beyond what lipid panels offer. It assesses the inflammatory component of atherosclerosis, a condition where plaque builds up in the arteries due to high cholesterol, especially elevated LDL levels. Understanding the inflammatory aspect can give a fuller picture of cardiovascular risk.

Incorporating the PLAC™ Test into your cardiovascular risk assessment can enhance the overall management strategy, providing a deeper understanding of heart health beyond cholesterol levels alone.

Request a quote today: https://bit.ly/47cIFv6

09/04/2025

National Cholesterol Education Month
🔬 Our applicable cutting-edge assays include:

LDL (Low-Density Lipoprotein): “Bad” cholesterol linked to plaque buildup in arteries.
HDL (High-Density Lipoprotein): “Good” cholesterol that helps remove excess cholesterol from the bloodstream.
Apo A-1: The major structural protein of HDL particles, playing a vital role in lipid metabolism and cardiovascular health.
Apo B: A key protein in LDL particles, providing more accurate risk assessments for heart disease.
oxLDL (Oxidized LDL): A modified form of LDL associated with inflammation and atherosclerosis, offering deeper insight into cardiovascular risk.
OxPL Apo B: Oxidized phospholipids bound to Apo B particles, a novel marker that further refines risk assessment for cardiovascular disease.
Lipoprotein(a) [Lp(a)]: A genetic risk factor for cardiovascular disease that requires specialized testing.
PLAC™: An innovative test measuring Lp-PLA2, an enzyme associated with plaque instability, offering deeper insights into cardiovascular risk.

💡 This month, let’s work together to raise awareness about cholesterol’s impact on heart health and equip clinicians with the latest tools to help patients live longer, healthier lives.

Find out more about how Diazyme’s diagnostic solutions can support effective cholesterol management.

https://bit.ly/3MlnU6y

08/28/2025

Employee Spotlight: Clara Lhotak
📍 Current Role: Department Assistant - Sales & Marketing

We’re excited to highlight Clara Lhotak, a valued member of the Diazyme team! Since joining Diazyme, she has expertly managed document requests with speed and precision, ensuring nothing falls through the cracks—even during high-volume periods. Clara's attention to detail and commitment to quality help us present our best work to clients and internal stakeholders alike!
💡 Career Journey at Diazyme
Clara began her journey with us as a part-time department assistant and has since grown into a role where she continues to contribute meaningfully to our mission of advancing diagnostic innovation.

“When I first started, I was supporting the department’s admin needs part-time and since then have been brought on for full time support. I now am also involved in other areas such as social media and product commercialization.”

🌟 Most Rewarding Experience
When asked about the most rewarding part of her work, Clara shared “Facilitating product registrations in other countries around the world – I enjoy being able to communicate with a large variety of people, cultures, and companies and am especially proud to know that we are supporting patient outcomes in so many corners of the world.”

🔬 On the Future of Diagnostics
Clara believes that innovation in diagnostics is transforming patient care. “As one of the first companies to launch an Alzheimer's panel, I’m looking forward to seeing how our contributions can reshape the clinical diagnostics field and help provide earlier insights to this complex and devasting disease.”

We’re proud to have dedicated team members like Clara who help drive Diazyme’s progress and commitment to better healthcare outcomes through cutting-edge diagnostics.

08/27/2025

Thank You for an Incredible ADLM 2025!

What a week! Diazyme was proud to join thousands of laboratory and diagnostics professionals at ADLM 2025 in Chicago, where we showcased our expanding portfolio of specialty assays and connected with partners from around the world.

From conversations at our booth to new collaborations and hands-on demos of the DZ-Lite c270, it was a week full of innovation, insights, and energy.

🎥 Catch the highlights from the show floor in our recap video below.

Thank you to everyone who stopped by, asked questions, and shared ideas. We're excited about what's ahead—and we’re proud to continue supporting laboratories with powerful, accessible diagnostic solutions.

Want to learn more or get in touch?
🔗 https://bit.ly/4l5t9GC

08/14/2025

DZ-Lite c270: Compact, Powerful, and Designed for Your Lab’s Efficiency

The DZ-Lite c270 is Diazyme’s fully automated clinical chemistry analyzer that combines high throughput with a small footprint — perfect for laboratories seeking reliable performance without compromising space.

Key features include:

- Up to 270 tests per hour throughput
- User-friendly touchscreen interface
- Flexible test menu with a broad range of assays
- Small footprint designed for space-conscious labs
- Seamless integration with Diazyme’s specialty assays

The DZ-Lite c270 supports labs in delivering fast, accurate results while optimizing workflow and operational efficiency.

Learn more: https://bit.ly/4kqOBW0

08/12/2025

Reliable Lp(a) Testing for Cardiovascular Risk Assessment

Lipoprotein(a) [Lp(a)] is increasingly recognized as a contributing factor in cardiovascular disease. According to the American Heart Association, elevated Lp(a) levels are associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD) and aortic valve stenosis.¹

Diazyme’s Lp(a) Assay offers laboratories a high-quality, flexible solution to support this growing area of testing:

- Excellent precision and accuracy
- No interference from apo(a) isoforms
- Liquid-stable reagents
- Compatible with most major chemistry analyzers
- Inquire about availability in nmol/L reporting

To learn more, visit: https://bit.ly/4lIqIu7

¹ American Heart Association. “Lipoprotein(a): Understanding a Little-Known Risk Factor for Cardiovascular Disease.” Scientific Statement, 2022.

08/06/2025

What an incredible week in Chicago at !
Thank you to everyone who stopped by the Diazyme booth — from longtime partners to new connections, we truly valued every conversation. Our team was proud to share how Diazyme is helping laboratories stay ahead with innovative and reliable diagnostic solutions.
A few highlights from the week:
✅ Connecting with leaders across the clinical diagnostics community
✅ Showcasing our Kappa and Lambda Free Light Chain (FLC) assays and Gastro Health Panel — two of our key specialty assays driving diagnostic insights
✅ Reuniting with customers and partners who continue to fuel our growth

We’re leaving Chicago inspired and full of momentum for what’s next. If we missed you at the show, let’s connect!

https://bit.ly/3HaqMnS

07/31/2025

That’s a wrap on ADLM 2025!

Thank you to all the clinical lab professionals, partners, and new faces who made this such a memorable event. We’re heading home energized and inspired.

📸 Check out some of our favorite moments below!

07/30/2025

Another inspiring day at ADLM 2025!

From educational presentations to real-time demos of our instrument, we’re proud to be at the center of innovation in lab diagnostics.

📍 Come see us at Booth #1814 — last chance tomorrow!

Address

12889 Gregg Court
Poway, CA
92064

Website

http://www.diazyme.com/

Alerts

Be the first to know and let us send you an email when Diazyme Laboratories, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your practice to be the top-listed Clinic in Poway?